NEPT vs. EVFM, CING, SXTC, ADTX, EVLO, SPRC, BXRX, TENX, OBSV, and BLPH
Should you be buying Neptune Wellness Solutions stock or one of its competitors? The main competitors of Neptune Wellness Solutions include Evofem Biosciences (EVFM), Cingulate (CING), China SXT Pharmaceuticals (SXTC), Aditxt (ADTX), Evelo Biosciences (EVLO), SciSparc (SPRC), Baudax Bio (BXRX), Tenax Therapeutics (TENX), ObsEva (OBSV), and Bellerophon Therapeutics (BLPH). These companies are all part of the "pharmaceutical preparations" industry.
Neptune Wellness Solutions (NASDAQ:NEPT) and Evofem Biosciences (NASDAQ:EVFM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability, dividends and community ranking.
Neptune Wellness Solutions has a beta of 2.19, indicating that its share price is 119% more volatile than the S&P 500. Comparatively, Evofem Biosciences has a beta of -1.19, indicating that its share price is 219% less volatile than the S&P 500.
Evofem Biosciences has a net margin of 344.82% compared to Neptune Wellness Solutions' net margin of -128.13%. Neptune Wellness Solutions' return on equity of 0.00% beat Evofem Biosciences' return on equity.
Evofem Biosciences received 110 more outperform votes than Neptune Wellness Solutions when rated by MarketBeat users. Likewise, 69.50% of users gave Evofem Biosciences an outperform vote while only 50.33% of users gave Neptune Wellness Solutions an outperform vote.
Neptune Wellness Solutions has higher revenue and earnings than Evofem Biosciences.
14.4% of Neptune Wellness Solutions shares are held by institutional investors. Comparatively, 0.2% of Evofem Biosciences shares are held by institutional investors. 5.1% of Neptune Wellness Solutions shares are held by insiders. Comparatively, 0.2% of Evofem Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Evofem Biosciences had 1 more articles in the media than Neptune Wellness Solutions. MarketBeat recorded 2 mentions for Evofem Biosciences and 1 mentions for Neptune Wellness Solutions. Evofem Biosciences' average media sentiment score of 0.95 beat Neptune Wellness Solutions' score of 0.77 indicating that Evofem Biosciences is being referred to more favorably in the news media.
Summary
Neptune Wellness Solutions and Evofem Biosciences tied by winning 6 of the 12 factors compared between the two stocks.
Get Neptune Wellness Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for NEPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NEPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Neptune Wellness Solutions Competitors List
Related Companies and Tools